Pentagastrin (ICI-50123) is a selective agonist ofCholecystokinin B (CCKB) receptor with an IC50 of 11nM. Pentagastrin enhances gastric mucosal defence mechanisms against acid and protects the gastric mucosa from experimenta...
Proglumide is a nonpeptide and orally activecholecystokinin (CCK)-A/B receptorsantagonist. Proglumide selective blocksCCK’s effects in the central nervous system (CNS). Proglumide has ability to inhibit gastric secretion a...
Gastrin-1, human is the endogenous peptide produced in the stomach, and increases gastric acid secretion viacholecystokinin 2 (CCK2)receptor.
Ceruletide is a decapeptide and a potentcholecystokinin receptoragonist. Ceruletide is a safe and effective cholecystokinetic agent with a direct spasmogenic effect on the gallbladder muscle and bile ducts.
Proglumide hemicalcium is a nonpeptide and orally activecholecystokinin (CCK)-A/B receptorsantagonist. Proglumide hemicalcium selective blocksCCK’s effects in the central nervous system (CNS). Proglumide hemicalcium has abi...
Proglumide sodium is a nonpeptide and orally activecholecystokinin (CCK)-A/B receptorsantagonist. Proglumide sodium selective blocksCCK’s effects in the central nervous system (CNS). Proglumide sodium has ability to inhibit...
Devazepide (L-364,718) is a potent, competitive, selective and orally active nonpeptide antagonist ofcholecystokinin (CCK) receptor, with IC50s of 81 pM, 45 pM and 245nM for rat pancreatic, bovine gallbladder and guinea pig ...
Dexloxiglumide is a selective cholecystokinin type A (CCKA) receptor antagonist. Dexloxiglumide, the active enantiomer of Loxiglumide, inhibits smooth muscle cell contractions induced by cholecystokinin-octapeptide (CCK-8).
Lintitript (SR 27897) is a highly potent, selective, orally active, competitive and non-peptidecholecystokinin (CCK1) receptorantagonist with an EC50 of 6nM and a Ki of 0.2nM. Lintitript displays > 33-fold selectivity more s...
CCK-B Receptor Antagonis...
CCK-B Receptor Antagonist 2, compound 15b, is a potent and orally activeGastrin/CCK-Bantagonist with an IC50 value of 0.43nM. CCK-B Receptor Antagonist 2 also inhibits gastrin/CCK-A activity with an IC50 of 1.82...
Sograzepide (Netazepide; YF 476; YM-220) is an extremely potent , highly selective and orally activeGastrin/CCK-Bantagonist with an IC50 value of 0.1nM, has inhibitory effect on Gastrin/CCK-A activity with an IC5...
Nastorazepide (Z-360) is a selective, orally available, 1,5-benzodiazepine-derivative gastrin/cholecystokinin 2 (CCK-2) receptor antagonist with potential antineoplastic activity.
in vitro: Z-360 binds to the gastri...
TELL : +86-020-31703347
Add:Room 519, Block F, Guangzhou International Business Incubator, No.3 Lanyue Road, Science Town, Huangpu District, Guangzhou, China.
ULS products are chemical reagents for Research Use Only！Copyright © 2020-2021 ULS. All Rights Reserved.